ReportingMassachusetts
Waltham's Sionna cuts about 46 percent of staff after cystic fibrosis trial miss

The biotech has not said how many jobs that is. It is dropping an add-on drug and shifting to a different combination.
Published
Loading coverage...
Independent reporting from across Massachusetts.

The biotech has not said how many jobs that is. It is dropping an add-on drug and shifting to a different combination.
Browse topics or check back for more local reporting.
Verified schedules will appear here. Check the organizer's official schedule for the latest information.